Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: Extracellular vesicle miRNAs for predicting the efficacy of late-line treatment with anlotinib in patients with lung adenocarcinoma

Fig. 5

KEGG/GO analysis of the differentially expressed sEV miRNAs. A Bubble plot of enriched GOs (biological process terms) of the target genes of the DEMs between the SD and PD groups. B A bubble plot of enriched GOs (cellular component and molecular function) of the target genes of the DEMs between the SD and PD groups. C Bubble plot of enriched KEGG pathways of target genes of the DEMs between the SD and PD groups

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us